Ronald C Renaud JR Insider Trading
Get free email notifications about insider trading for Ronald C Renaud JR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ronald C Renaud JR. Ronald C Renaud JR is a Chief Financial Officer in KERYX BIOPHARMACEUTICALS INC ($KERX) and a Director in CHIMERIX INC ($CMRX) and a Director in PTC THERAPEUTICS, INC. ($PTCT) and a in Akebia Therapeutics, Inc. ($AKBA) and a Director in Akebia Therapeutics, Inc. ($AKBA) and a in Atara Biotherapeutics, Inc. ($ATRA) and a Director in Atara Biotherapeutics, Inc. ($ATRA) and an Chief Executive Officer in Translate Bio, Inc. ($TBIO) and an Chief Executive Officer, Pres. in Translate Bio, Inc. ($TBIO) and a See Remarks in Translate Bio, Inc. ($TBIO).
Address: C/O KERYX BIOPHARMACEUTICALS, INC. 750 LEXINGTON AVENUE NEW YORK 10022 NY
Companies in which Ronald C Renaud JR is an Insider
Akebia Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ronald C Renaud JR:
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 15 2018
$AKBA Market Capitalization: $177.33M
$AKBA Previous Close: $9.88
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Atara Biotherapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ronald C Renaud JR:
Holdings: 11,000 shares
Current Value: $165,550
Latest Transaction: Jun 09 2021
$ATRA Market Capitalization: $434.34M
$ATRA Previous Close: $15.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CHIMERIX INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ronald C Renaud JR: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 24 2019
$CMRX Market Capitalization: $255.66M
$CMRX Previous Close: $5.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
KERYX BIOPHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ronald C Renaud JR: Chief Financial Officer
Holdings: 94,027 shares
Current Value: $503,044
Latest Transaction: Feb 16 2007
$KERX Market Capitalization: $574.30M
$KERX Previous Close: $5.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PTC THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ronald C Renaud JR: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 05 2017
$PTCT Market Capitalization: $452.34M
$PTCT Previous Close: $13.46
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Translate Bio, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ronald C Renaud JR: Chief Executive Officer, Pres., Chief Executive Officer, See Remarks
Holdings: 503,321 shares
Latest Transaction: Apr 09 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Ronald C Renaud JR
Sentiment: All, AKBA, ATRA, CMRX, KERX, PTCT, TBIO
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 09 2021 | ATRA | Atara Biotherapeut ... | Renaud Ronald C JR | Option Exercise | A | 13.80 | 17,500 | 241,500 | 17,500 | ||
| Jun 09 2021 | ATRA | Atara Biotherapeut ... | Renaud Ronald C JR | Grant | A | 0.00 | 11,000 | 0 | 11,000 | 0 to 11 K | |
| Apr 09 2021 | TBIO | Translate Bio, Inc ... | Renaud Ronald C JR | Chief Executive Off ... | Option Exercise | M | 7.39 | 9,026 | 66,702 | 1,071,009 | |
| Apr 09 2021 | TBIO | Translate Bio, Inc ... | Renaud Ronald C JR | Chief Executive Off ... | Buy | M | 7.39 | 9,026 | 66,702 | 503,321 | 494.3 K to 503.3 K (+1.83 %) |
| Mar 09 2021 | TBIO | Translate Bio, Inc ... | Renaud Ronald C JR | Chief Executive Off ... | Option Exercise | A | 23.82 | 325,000 | 7,741,500 | 325,000 | |
| Jan 14 2021 | TBIO | Translate Bio, Inc ... | Renaud Ronald C JR | Chief Executive Off ... | Option Exercise | M | 8.34 | 1 | 8 | 89,996 | |
| Jan 14 2021 | TBIO | Translate Bio, Inc ... | Renaud Ronald C JR | Chief Executive Off ... | Option Exercise | M | 7.39 | 5,638 | 41,665 | 1,080,035 |